Cargando…

Editorial: Epigenetic regulation and therapy resistance in cancer

Detalles Bibliográficos
Autores principales:	Zhu, Yongxia, Pittella-Silva, Fabio, Wang, Yuxi, Wang, Ting, Long, Fangyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868549/ https://www.ncbi.nlm.nih.gov/pubmed/36699076 http://dx.doi.org/10.3389/fphar.2022.1119073

Ejemplares similares

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Editorial: Adaptive immune resistance in cancer therapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
por: Lin, Xiaoping, et al.
Publicado: (2022)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
por: Zhou, Fanfan, et al.
Publicado: (2022)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
por: Lin, Hong, et al.
Publicado: (2022)

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Editorial: Advances in antimicrobial therapy and combating resistance
por: Ghazi, Islam M., et al.
Publicado: (2023)

Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
por: Xiao, Wenjing, et al.
Publicado: (2021)

Atractylenolide-I Suppresses Tumorigenesis of Breast Cancer by Inhibiting Toll-Like Receptor 4-Mediated Nuclear Factor-κB Signaling Pathway
por: Long, Fangyi, et al.
Publicado: (2020)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Jaafari, Abdeslam, et al.
Publicado: (2022)

The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis
por: Zhang, Yixuan, et al.
Publicado: (2022)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Editorial: Local and traditional medicine in regulation of the cancer immune suppression microenvironment, Volume II
por: Hong, Shicui, et al.
Publicado: (2023)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
por: Lovato, Amanda, et al.
Publicado: (2012)

Editorial: Novel small molecules in targeted cancer therapy
por: Li, Rong, et al.
Publicado: (2023)

Editorial: Thyroid cancer: New perspectives in diagnosis and therapy
por: Sarkar, Rhitajit, et al.
Publicado: (2022)

Editorial: Molecular basis of epigenetic regulation in cancer therapies
por: Carlos-Reyes, Angeles, et al.
Publicado: (2023)

Editorial: Natural products in regulating mitochondrial dysfunction
por: Xie, Caifeng, et al.
Publicado: (2023)

Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer
por: Tuli, Hardeep Singh, et al.
Publicado: (2023)

Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes
por: Lu, Meng, et al.
Publicado: (2022)

Editorial: Nanoparticles in Cancer Therapy-Novel Concepts, Mechanisms, and Applications
por: Mu, Qingxin, et al.
Publicado: (2019)

Editorial: Mitochondrial therapy in neurodegeneration
por: Kalani, Anuradha, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2
por: Zhang, Cheng, et al.
Publicado: (2022)

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators
por: Liu, Yang, et al.
Publicado: (2023)

Maintenance of glutathione levels and its importance in epigenetic regulation
por: García-Giménez, José L., et al.
Publicado: (2014)

Editorial: Cancer therapy: The challenge of handling a double-edged sword
por: Nurgali, Kulmira, et al.
Publicado: (2022)

Editorial: New Therapies in the Field of Rheumatology
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023)

Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
por: Su, Chao-Yue, et al.
Publicado: (2023)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7thgk5cnr1drr0qd7ul66g33po